Joseph J. Wolk - 13 Dec 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Exec VP, CFO
Signature
Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk
Issuer symbol
JNJ
Transactions as of
13 Dec 2022
Net transactions value
-$1,351,072
Form type
4
Filing time
15 Dec 2022, 15:34:45 UTC
Previous filing
17 Feb 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Gift $0 -18 -0.05% $0.000000 35,840 20 Apr 2022 Direct
transaction JNJ Common Stock Gift $0 -28 -0.08% $0.000000 35,812 20 Apr 2022 Direct
transaction JNJ Common Stock Options Exercise $1,169,027 +12,926 +36% $90.44 48,738 13 Dec 2022 Direct
transaction JNJ Common Stock Options Exercise $134,562 +1,855 +3.8% $72.54 50,593 13 Dec 2022 Direct
transaction JNJ Common Stock Sale $332,906 -1,855 -3.7% $179.46 48,738 13 Dec 2022 Direct
transaction JNJ Common Stock Sale $2,321,755 -12,926 -27% $179.62 35,812 13 Dec 2022 Direct F1
holding JNJ Common Stock 1,988 13 Dec 2022 By 401k F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -1,855 -100% $0.000000* 0 13 Dec 2022 Common Stock 1,855 $72.54 Direct
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -12,926 -100% $0.000000* 0 13 Dec 2022 Common Stock 12,926 $90.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $179.610 to $179.670. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Stock Fund Dividends Accrued: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (11/30/2022)